MedTrace Logo

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

NCT02049814 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 494

Last updated 2019-03-13

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to evaluate the efficacy of voglibose versus acarbose combined with metformin in participants with type 2 diabetes mellitus (T2DM) by evaluating levels of glycosylated hemoglobin.

Conditions

Interventions

DRUG

Metformin

Metformin tablets

DRUG

Voglibose

Voglibose tablets

DRUG

Acarbose

Acarbose tablets

Sponsors & Collaborators

Principal Investigators

  • Medical Director, Clinical Science · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-09
Primary Completion
2016-06-01
Completion
2016-06-28

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049814 on ClinicalTrials.gov